Artificial Intelligence in Drug Discovery Market Size to Reach $ 2,015.1 Million by 2025

Overview of the Artificial Intelligence in Drug Discovery Market

According to MRFR reports, the AI in the drug discovery market is likely to cross market value of over $ 2,015.1 million while registering a robust 40.8% CAGR throughout the forecast period of 2019 to 2025.

The global AI in drug discovery market has seen massive growth in recent times due to factors such as huge investments in AI industry by major players, growing number of startups, Growing adoption of AI by large pharmaceutical companies for drug discovery, and the growing number of mergers and partnerships. However, market growth is expected to be hampered by the lack of adequate infrastructure in developing economies and the high cost of integrating AI.

Get Custom Sample With Complete Table Of Contents Including COVID-19 Industry Analysis @ https://www.marketresearchfuture.com/sample_request/9393

Segment analysis

The global AI for drug discovery market is divided into numerous segments based on product type, molecule type, technology, indication, application, and region.

The global market is divided into services and software based on the type of product.

By Molecule Type, the market is split into Small and Large Molecules.

Based on technology, the global market is divided into deep learning, machine learning, and others.

Global market by indication is divided into Metabolic, Cardiovascular, Neurodegenerative, Immuno-oncology, and others.

On the basis of the applications, the global market is divided into preclinical testing, de novo drug design, drug optimization and reuse, candidate selection, target identification, and others.

The global market is divided into academic and government research centers and institutes, contract research organizations, and pharmaceutical and biotechnology companies by end users.

Ask the Experts @ https://www.marketresearchfuture.com/enquiry/9393

Regional analysis

Global AI in the drug discovery market is studied in four major regions: the Americas, Europe, Asia-Pacific, Middle East and Africa.

The American region is expected to hold the first position in the world market during the forecast period. The growth of the regional market is driven by aspects such as the growing number of large AI platform developers present in the region, the increasing demand for artificial intelligence technologies from large pharmaceutical companies and the growth of demand for new drugs in Latin America. The United States and Canada dominate the regional market with the maximum contribution to net market share.

The European regional market for AI in drug discovery is expected to secure the second position in the global market. The growth of the regional market is driven by the increasing demand for AI solutions by large pharmaceutical companies, the growth of R&D activities in the pharmaceutical sector and the growing number of startups in the region.

The Asia-Pacific region is likely to experience the fastest growth rate throughout the 2019-2027 review period in the Drug Discovery AI market. The growth of the regional market is attributed to the rapid growth of the pharmaceutical market, the growing number of startups and the growing demand for effective drug discovery solutions.

AI in Drug Discovery Market for Middle East & Africa region is expected to register the lowest growth over the forecast period due to low disposable income per capita, limited number of players working in drug discovery and development and limited health infrastructure.

Competitive analysis

Global AI in the drug discovery market has an extremely competitive landscape. Players around the world are focused on strengthening their market position by expanding their customer base. The list of major players in the Artificial Intelligence in Drug Discovery market includes Berg LLC, Xtalpi, Inc., Twoxar, Incorporated, Numedii, Inc., Bioage, Exscientia, Insilico Medicine, Deep Genomics, Google (a subsidiary of ‘Alphabet Inc.), Microsoft Corporation, Verge Genomics, Owkin, Inc., Envisagenics, Numerate, Cyclica, BenevolentAI, Cloud Pharmaceuticals, Inc., Atomwise, Inc., IBM Corporation and many others.

Get Premium Research Report, Including COVID-19 Impact Analysis, Find More Information @ https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393

Recent developments

November 2021 – A new Alphabet company, Isomorphic Laboratories, is set to create the latest tools to help recognize new pharmaceuticals. Demis Hassabis, CEO of DeepMind, will also be the CEO of a new company, but the two companies will operate in a safe manner and work together occasionally.

November 2021 – Roche and its Genentech division appointed Flywheel, a curation developer, to train its machine learning models focused on discovering potential new drugs.

The Flywheel platform offers help to automate the ingestion, analysis and classification of medical images collected from digital pathology programs and radiological analyzes and data from diagnostic tests and electronic health records.

Contents

1. SUMMARY

1.1. Market attractiveness analysis

1.1.1. Global AI in Drug Discovery Market, By Product Type

1.1.2. Global AI in Drug Discovery Market, By Molecule Type

1.1.3. Global AI in Drug Discovery Market, By Technology

1.1.4. Global AI in Drug Discovery Market, By Indication

1.1.5. Global AI in Drug Discovery Market, By Application

1.1.6. Global AI in Drug Discovery Market, By End User

2. INTRODUCTION TO THE MARKET

2.1. Definition

2.2. Scope of the study

2.2.1. Research objective

2.2.2. Hypotheses

2.2.3. Limits

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data mining

3.2.1. Secondary research

3.2.2. Primary research

3.2.2.1. Distribution of main respondents

3.2.3. Forecasting techniques

3.3. Research methodology for estimating market size

3.3.1. An in-depth approach

3.3.2. Top-down approach

3.4. Data triangulation

3.5. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Conductors

4.3. Constraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

… Continued from the table of contents…

To learn more, see the healthcare reports:

ELISpot and FluoroSpot Assays Market Research Report – Global Forecast to 2027
Biochips Market Research Report – Global Forecast to 2027
Nasal Splints Market Research Report – Global Forecast to 2027
Sleep Testing Services Market Research Report – Global Forecast to 2027
Sexual Well-Being Market Research Report – Global Forecast to 2027
Preclinical Imaging Market Research Report – Forecast to 2027
Chlorhexidine Gluconate Wipes Market Research Report – Forecast to 2027
Global Healthcare RFID Market Industry Size, Share, Analysis and Forecast to 2027
Urinary Catheters Market Research Report – Forecast to 2027
Endodontic Devices Market Research Report – Forecast to 2027

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, providing comprehensive and accurate analysis with respect to various markets and consumers around the world. Market Research Future has a distinguished goal of providing high-quality research and granular research to customers. Our market research by products, services, technologies, applications, end users and market players for global, regional and national market segments, enables our clients to see more, learn more and do more, which helps answer your most important questions. questions.

Follow us: LinkedIn | Twitter

Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5th Floor, New York,
New-York 10013,
united states of america
E-mail: [email protected]
Website:
https://www.marketresearchfuture.com



Source link

Comments are closed.